Clinical Reference Values for Left Ventricular Diastolic Indices in Stable Outpatients with Heart Failure with Reduced Ejection Fraction Running Title: Diastolic Reference Values in HfrEF
Background and Aim: Heart failure with reduced ejection fraction (HFrEF) requires precise assessment of left ventricular filling pressures (LVFP) for optimal management. While guidelines provide thresholds for detecting elevated LVFP, specific reference values for guiding hemodynamic targets in stable outpatients remain undefined. This study aimed to establish clinical reference values for echocardiographic diastolic indices in stable HFrEF patients. Methods This cross-sectional study was conducted in 2023 at the Cardiovascular Research Center of Tabriz University of Medical Sciences. A total of 102 outpatient HFrEF patients (ejection fraction ≤ 40%, NYHA functional class I/II) and 100 healthy individuals with normal cardiac function (ejection fraction ≥ 55%) were enrolled. Patients with significant valvular disease, atrial fibrillation, advanced pulmonary disease, or severe renal failure (eGFR < 30 mL/min) were excluded. Diastolic indices, including left atrial volume index (LAVI), tricuspid regurgitation gradient (TRG), E/e′ ratio, and E/A ratio, were measured using transthoracic echocardiography. Data were analyzed using the Mann-Whitney test in SPSS version 22 (significance level P < 0.05). Results Mean diastolic indices in HFrEF patients were LAVI: 32.5 mL/m² (vs. 25 mL/m² in controls), TRG: 21.5 mmHg (vs. 16.5 mmHg), and E/e′: 12 (vs. 7), all significantly higher than the control group (P < 0.0001). The E/A ratio (0.95 in patients vs. 0.8 in controls) showed no significant difference (P = 0.171). Conclusion The diastolic indices LAVI (32.5 mL/m²), TRG (21.5 mmHg), and E/e′ (12) can serve as clinical reference points for optimizing medical treatment in ambulatory HFrEF patients and for guiding clinical decision-making, as these patients may require drug adjustment to prevent pulmonary congestion and hospital readmissions. Further research is needed to validate these findings and assess their impact on long-term outcomes.
Authors
- Maryam Chenaghlou (ORCID: https://orcid.org/0000-0002-2376-0913)
- Mahdi Karimi (ORCID: https://orcid.org/0000-0002-1225-6287)
- Kamran Mohammadi (ORCID: https://orcid.org/0000-0002-8300-8547)
- Ataolla Eskandari
Institutions
- Ahvaz Jundishapur University of Medical Sciences (IR)
- Tabriz University of Medical Sciences (IR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11099792/v1
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- preprint
Funders
- Tabriz University of Medical Sciences